Prostate cancer has distinct genetic properties in different groups of men that can be targeted to improve patient outcomes, ...

Prostate cancer has distinct genetic properties in different groups of men that could be targeted to improve patient outcomes, new research suggests.

Prostate cancer has distinct genetic properties in different groups of men that can be targeted to improve patient outcomes, UVA Cancer Center researchers have discovered.

For the men with the highest genetic risk, the test falsely identified fewer people with prostate cancer than the PSA test, picked up people with cancer who would have been missed by the PSA test ...

A biomarker, PROSTOX, predicted late genitourinary toxicity accurately in patients with prostate cancer, yielding an area under the curve of 0.76.

We have shown that a relatively simple, inexpensive spit test to identify men of European heritage at higher risk due to their genetic makeup is an effective tool to catch prostate cancer early.

Unique pathways involved in each form of GU toxicity (acute, chronic, and late) were identified in a gene ontology analysis ... the safest course of [prostate cancer] treatment to avoid ...

Building on these findings, the team emphasizes the importance of integrating genetic testing with modern radiation therapy to further personalize prostate cancer treatment. "This genre of genetic ...

Don't miss out on the headlines from Cancer. Followed categories will be added to My News. The test, which analyses genetic variants ... the spit test falsely identified prostate cancer in fewer ...